Directory
Elias Jatem Escalante

Elias Jatem Escalante

Degree: Graduate


Groups

Publications

  • Roca N; Jatem E; Martín ML; Muñoz M; Molina M; Martínez C; Segarra A

    Relationship between soluble urokinase-type plasminogen activator receptor and serum biomarkers of endothelial activation in patients with idiopathic nephrotic syndrome.

    CLINICAL KIDNEY JOURNAL 14 543-549. .

    [doi:10.1093/ckj/sfz173]

  • Jatem, E; Lima, J; Montoro, B; Torres-Bondia, F; Segarra, A

    Efficacy and Safety of PCSK9 Inhibitors in Hypercholesterolemia Associated With Refractory Nephrotic Syndrome

    Kidney International Reports 6 101-109. .

    [doi:10.1016/j.ekir.2020.09.046]

  • Segarra, A; Arredondo, KV; Jaramillo, J; Jatem, E; Salcedo, MT; Agraz, I; Ramos, N; Carnicer, C; Valtierra, N; Ostos, E

    Efficacy and safety of bortezomib in refractory lupus nephritis: a single-center experience.

    Lupus 29 118-125. .

    [doi:10.1177/0961203319896018]

  • Segarra, A; Martinez, C; Carnicer, C; Perich, C; Jatem, E; Martin, M

    Analytical and Biological Variability of Urinary Epidermal Growth Factor-to-Creatinine Ratio in Patients with Chronic Kidney Disease and in Healthy Volunteers

    CLINICAL LABORATORY 65 2035-2041. .

    [doi:10.7754/Clin.Lab.2019.190304]

  • Segarra, A; Carnicer, C; Jatem, E; Martin, M; Molina, M; Perich, C; Martinez, C

    Accuracy of Urinary Epidermal Growth Factor to Creatinine Ratio to Predict 24-Hour Urine Epidermal Growth Factor and Interstitial Kidney Fibrosis in Patients with IgA Nephropathy

    CLINICAL LABORATORY 65 1033-1039. .

    [doi:10.7754/Clin.Lab.2018.181122]